Finance

Lists
LH:NYSE
Labcorp Holdings Inc
$ 308.11
-0.23%
(-0.70) 1D
$ 308.11
0.00% (0.00)
After hours
Closed: 9-р сарын 30, 16:00:05 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
$ 311.00
High
$ 311.54
Low
$ 306.98
Mkt. cap
24.99 тэрбум
Avg. vol.
768.56 мян
Volume
646.17 мян
Dividend
0.93%
Quarterly dividend
$ 0.72
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
25.48
52-wk high
$ 341.80
52-wk low
$ 244.52
EPS
$ 12.09
Beta
0.88
Shares outstanding
81.10 сая
No. of employees
71 мян
Open
$ 311.00
High
$ 311.54
Low
$ 306.98
Mkt. cap
24.99 тэрбум
Avg. vol.
768.56 мян
Volume
646.17 мян
Dividend
0.93%
Quarterly dividend
$ 0.72
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
25.48
52-wk high
$ 341.80
52-wk low
$ 244.52
EPS
$ 12.09
Beta
0.88
Shares outstanding
81.10 сая
No. of employees
71 мян
News stories
From web sources and news partners
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71 мян
Founded1978
HeadquartersBurlington, Хойд Каролина, Америкийн Нэгдсэн Улс
SectorHealth care provider
Analyst ratings
Based on 13 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current $ 308.11
$ 380.00 (+23.33%)
Average
$ 343.50 (+11.49%)
Lowest
$ 306.00 (-0.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Cherny
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
David S Macdonald
Truist Financial
Buy
Maintained
$ 365.00
+18.5%
09/21/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$ 340.00
+10.4%
09/11/2026
Kevin Caliendo
UBS
Buy
Maintained
$ 380.00
+23.3%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Luke Sergott
Barclays
Hold
Maintained
$ 330.00
+7.1%
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$ 355.00
+15.2%
08/10/2026
David Westenberg
Piper Sandler
Hold
Reiterated
$ 309.00
+0.3%
08/04/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
$ 306.00
-0.7%
07/31/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$ 338.00
+9.7%
07/31/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$ 352.00
+14.2%
07/31/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
$ 360.00
+16.8%
07/30/2026
David Toung
Argus Research
Buy
Maintained
$ 310.00
+0.6%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
$ 320.00
+3.9%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Last report
2026 оны 7-р сарын 30
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 4.99 / $ 4.77
+4.65%beat
Revenue / Est. (USD)
3.73 тэрбум / 3.71 тэрбум
+0.47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
3.56 тэрбум
3.52 тэрбум
3.54 тэрбум
3.73 тэрбум
Cost of goods sold
2.54 тэрбум
2.52 тэрбум
2.52 тэрбум
2.62 тэрбум
Cost of revenue
2.54 тэрбум
2.52 тэрбум
2.52 тэрбум
2.62 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
552.40 сая
549.70 сая
551.00 сая
577.20 сая
Operating expense
621.90 сая
622.30 сая
626.60 сая
655.30 сая
Total operating expenses
3.16 тэрбум
3.14 тэрбум
3.15 тэрбум
3.27 тэрбум
Operating income
403.20 сая
370.90 сая
387.20 сая
456.70 сая
Other non operating income
700.00 мян
1.90 сая
-600.00 мян
-3.50 сая
EBT including unusual items
337.00 сая
190.60 сая
319.70 сая
386.40 сая
EBT excluding unusual items
341.30 сая
315.20 сая
333.20 сая
391.50 сая
Income tax expense
75.50 сая
25.70 сая
41.70 сая
87.30 сая
Effective tax rate
22.40%
13.48%
13.04%
22.59%
Other operating expenses
-
-
-
-
Net income
261.10 сая
164.70 сая
277.80 сая
298.70 сая
Net profit margin
7.33%
4.68%
7.85%
8.01%
Earnings per share
4.18
4.07
4.25
4.99
Interest and investment income
3.50 сая
3.50 сая
12.20 сая
5.60 сая
Interest expense
-56.00 сая
-55.00 сая
-55.10 сая
-61.10 сая
Net interest expenses
-52.50 сая
-51.50 сая
-42.90 сая
-55.50 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
574.20 сая
549.40 сая
560.50 сая
635.70 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс